| 000 | 01720 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250514033503.0 | ||
| 264 | 0 | _c20021217 | |
| 008 | 200212s 0 0 eng d | ||
| 022 | _a0969-8051 | ||
| 024 | 7 |
_a10.1016/s0969-8051(02)00290-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHu, Fang | |
| 245 | 0 | 0 |
_aPm-149 DOTA bombesin analogs for potential radiotherapy. in vivo comparison with Sm-153 and Lu-177 labeled DO3A-amide-betaAla-BBN(7-14)NH(2). _h[electronic resource] |
| 260 |
_bNuclear medicine and biology _cMay 2002 |
||
| 300 |
_a423-30 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBombesin _xanalogs & derivatives |
| 650 | 0 | 4 |
_aHeterocyclic Compounds, 1-Ring _xchemical synthesis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLutetium _xpharmacokinetics |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMetabolic Clearance Rate |
| 650 | 0 | 4 |
_aMetals, Rare Earth _xpharmacokinetics |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aPeptide Fragments _xchemical synthesis |
| 650 | 0 | 4 |
_aPromethium _xpharmacokinetics |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xmetabolism |
| 650 | 0 | 4 |
_aRadiopharmaceuticals _xpharmacokinetics |
| 650 | 0 | 4 | _aReproducibility of Results |
| 650 | 0 | 4 |
_aSamarium _xpharmacokinetics |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 650 | 0 | 4 | _aTissue Distribution |
| 700 | 1 | _aCutler, Cathy S | |
| 700 | 1 | _aHoffman, Timothy | |
| 700 | 1 | _aSieckman, Gary | |
| 700 | 1 | _aVolkert, Wynn A | |
| 700 | 1 | _aJurisson, Silvia S | |
| 773 | 0 |
_tNuclear medicine and biology _gvol. 29 _gno. 4 _gp. 423-30 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0969-8051(02)00290-1 _zAvailable from publisher's website |
| 999 |
_c11929244 _d11929244 |
||